期刊文献+

低密度脂蛋白胆固醇水平与帕金森病的关系 被引量:5

Research about relationship between low density lipid cholesterol levels and Parkinson's disease
下载PDF
导出
摘要 目的探讨低密度脂蛋白胆固醇与帕金森病(PD)的关系。方法对门诊就诊的PD患者及健康对照者进行一般情况调查,并抽血化验胆固醇、甘油三酯、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇。对两组检查结果进行统计分析,对所有可能与PD发病有关的因素纳入Logistic回归分析。结果PD组血脂各项指标均低于正常对照组,但无统计学意义;Logistic回归分析显示家族史与PD发病有阳性关联。结论低密度脂蛋白胆固醇与PD发病之间的关系尚待研究,家族史是PD发病的危险因素之一。 Objective To investigate the relationship between LDL-C and PD. Methods Case-control study were carried out. Fasting lipid profiles were obtained from 54 PD cases and 50 controls, and the PD eases were recruited from eases presenting at our PD clinic, and controls were recruited from the medical examination populations of the same clinic. Results The triglyeerides ,total cholesterol,HDL-C and LDL-C were lower than control group, however did not reach significant difference. The family history related to PD by Logistic analysis(P〈0.05). Conclusions No relationship is confirmed between LDL-C and PD,and the family history is a risk factor to PD.
出处 《解放军保健医学杂志》 2008年第1期11-13,共3页 Journal Of Health Care And Medicine in Chinese Pla
关键词 帕金森病 低密度脂蛋白胆固醇 分析 Parkinson's disease Low density lipid cholesterol analysis
  • 相关文献

参考文献13

  • 1陈海波 王新德.统一帕金森病评定量表[J].中华老年医学杂志,1999,18(1):61-62.
  • 2[2]Pericak-vance MA,Haines JL.Genetic susceptibility to Alzheimer disease[J].Trends Genet,1995,11:504-508.
  • 3[3]National Institute of Aging/Alzheimer Association Working Group,Apolipoprotein E genotyping in Alzheimer's disease[J].Lancet,1996,347:1091-1095.
  • 4[4]Elbaz A,Bower JH,Maraganore DM,.et al.Risk tables for Parkinsonism and Parkinson's disease[J].J Clin Epidemiol,2002,55:25-31.
  • 5[5]Zareparsi S,Camicioli R,Sexton G,et al.Age of onset of Parkinson disease and apolipoprotein E genotypes[J].Am J Med Genet,2002,111:459-469.
  • 6[6]Musanti R,Parati E,Lamperti E,et al.Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease[J].Biochem Med Metab Biol,1993,49:133-142.
  • 7[7]Ettinger WH Jr,Harris T.Causes of hypocholesterolemia[J].Coron Artery Dis,1993,4:854-859.
  • 8[8]Iribarren C,Reed DM,Chen R,et al.Low serum cholesterol and mortality.Which is the cause and which is the effect?[J].Circulation,1995,92:2396-2403.
  • 9[9]Xuemei Huang,Honglei Chen,William C,et al.Lower low density lipid cholesterol levels are associated with Parkinson's disease[J].Proc Natl Acad Sci U S A,2007,104:955-960.
  • 10[10]Lamperti E.Decreased concentration of low density lipoprotein cholesterol in patients with Parkinson's disease.In:Musanti R,Rocca N,Ghiselli G,Parati E.Clinical research[M].Vol.39.1991.401A.

二级参考文献7

  • 1[1]Lang D,Kredan MB,Moat SJ,et al.Homocysteine induced inhibition of endothelium dependent relaxation in relaxation in rabbit aorta:role for superoxide anions[J].Arterioscler Thromb Vasc boil,2000,20:422 ~ 427
  • 2[2]Outinenen PA,Sood SK,Pfeier SI,et al.Homocysteine-induced endoplasmic peticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells[J].Blood,1999,94:959 ~967
  • 3[3]Serhat Ozkan,Omer Colak,Ceyhan Kutlu,et al.Plasma homocysteine levels in pergolide treated parkinson disease patients[J].Clin Neuropharmacol,2004,27(4):163~ 165
  • 4[4]Blandini F,Fancellu R,Martignoni E,et al.Plasma homocysteine and L-dopa metabolism in patients with Parkinson disease[J].Clin Chem,2001,47:1102~1104
  • 5[5]JW Miller,J Selhub,MR Nadeau,et al.Effect of L-dopa on plasma homocysteine in PD patients relationship to B-vitamin status[J].Neurology,2003,60:1125~1129
  • 6张春燕,朱星红.大鼠纹状体毛细血管密度的体视学研究[J].中国老年学杂志,2001,21(3):226-227. 被引量:8
  • 7傅毅,刘建荣,陈生弟.同型半胱氨酸与脑血管病[J].临床神经病学杂志,2003,16(3):189-190. 被引量:30

共引文献78

同被引文献32

  • 1张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 2史蕙青,张博爱,贾延劼,陈烈冉.血浆同型半胱氨酸的水平与帕金森病之间的关系[J].中国实用神经疾病杂志,2006,9(6):48-49. 被引量:9
  • 3张振涛,曹学兵,孙圣刚.帕金森病多巴胺神经元死亡的分子机制[J].中国康复,2006,21(6):402-404. 被引量:17
  • 4Nanhoe-Mahabier W,de Laat K F,Visser J E,et al.Parkinson disease and comorbid cerebrovasculardisease[J].Nat Rev Neurol,2009,5(10):533-541.
  • 5O'Suilleabhain P E,Sung V,Hernandez C,et al.Elevated plasma ho-mocysteine level in patients with Parkinson disease:motor,affective,and cognitive associations[J].Arch Neural,2004,61 (6):865-868.
  • 6Zoccolella S,Dell' aquila C,Specchio LM,et al.Elevatd Homocys-teine Levels in Parkinson' s Disease:Is there Anything Besides L-Dope Treatment[J].Curr Med Chem,2009,24(8):1034-1037.
  • 7Yuan R Y,Sheu JJ,Yu J M,et al.Methylenetetrahydrofolate reduc-tase palymorphisms an plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients[J].J Neurol Sci,2009,287(1-2):64-68.
  • 8Hu G,Jousilahti P,Bidel S,et al.Type 2 diabetes and the risk of Parkinson' s disease[J].Diabetes Care,2007,30(4):842-847.
  • 9Bedrood S,Jayasinghe S,Sieburth D,et al.Annexin A5 directly interacts with amyloidogenic proteins and reduces their toxiciry[J].Biochemistry,2009,48(44):10568-10576.
  • 10Huang X,Abbott R D,Petrovitch H,et al.Low LDL cholesterol and increased risk of Parkinson's disease:prospective results from Honolulu-Asia Aging Study[J].Mov Disord,2008,23(7):1013-1018.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部